Rachel Walczyk, PA

Rachel Walczyk practices at Olean Medical Group in Salamanca, New York.

Rachel Walczyk's NPI, 1699181693, was assigned on July 10, 2014. Rachel Walczyk holds New York license 017604.

Rachel Walczyk's primary practice is Olean Medical Group, at 449 Broad St, Salamanca, NY 14779 in Cattaraugus County. The practice phone is (716) 945-4770.

Rachel Walczyk's primary practice is Olean Medical Group in Salamanca, New York. Rachel Walczyk is also affiliated with Buffalo General Medical Center/Gates Vascular Institute. The medical group on file is Olean Medical Group. Dmand AI also links Rachel Walczyk to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rachel Walczyk practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Rachel Walczyk's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Rachel Walczyk is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Rachel Walczyk is licensed in New York.

Dmand AI lists acute sinusitis, acute skin infection, arthritis, asthma, bronchitis, chronic kidney disease, chronic nasal allergies and chronic obstructive pulmonary disease (COPD) among the conditions Rachel Walczyk treats.

CMS data shows 239 Medicare services from Rachel Walczyk across 6 procedure codes in 2024, for 102 Medicare patients. Medicare paid $14,552 for them. Every service was in an office.

CMS counts 102 Medicare patients who saw Rachel Walczyk in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Rachel Walczyk's median patient age at 62, with 58% women.

In 2024, Rachel Walczyk wrote 4,658 Medicare Part D claims for 471 patients. 87% of them were for generic drugs. CMS names the drug for 3,988 of them, across 96 drugs with 11 or more claims each, at $315,316 in total drug cost.

Rachel Walczyk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rachel Walczyk as offering telehealth.

CMS Open Payments shows 38 general payments to Rachel Walczyk from 9 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $168.